Presidio Pharmaceuticals Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • 2ndary - Private

Presidio Pharmaceuticals General Information

Description

Developer of small-molecule antiviral therapeutics designed to treat viral infections. The company's antiviral therapeutics offer daily oral dosing and can be combined with other classes of antivirals to combat viral resistance, enabling patients to access effective drug therapies against a variety of known hepatitis genotypes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1700 Owens Street
  • Suite 184
  • San Francisco, CA 94158
  • United States
+1 (415)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 1700 Owens Street
  • Suite 184
  • San Francisco, CA 94158
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Presidio Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Jan-2021 Completed Clinical Trials - General
5. Later Stage VC (Series D) 13-Jun-2014 Completed Clinical Trials - General
4. Merger/Acquisition 30-Nov-2012 Cancelled Clinical Trials - General
3. Later Stage VC (Series C) 02-Nov-2012 Completed Clinical Trials - General
2. Early Stage VC (Series B) 09-Jul-2009 $27M $54.5M Completed Startup
1. Early Stage VC (Series A) 07-Jun-2006 $27.5M $27.5M Completed Startup
To view Presidio Pharmaceuticals’s complete valuation and funding history, request access »

Presidio Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
To view Presidio Pharmaceuticals’s complete cap table history, request access »

Presidio Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of small-molecule antiviral therapeutics designed to treat viral infections. The company's antiviral therapeut
Drug Discovery
San Francisco, CA
12 As of 2015

Durham, NC
 

Tucson, AZ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Presidio Pharmaceuticals Competitors (12)

One of Presidio Pharmaceuticals’s 12 competitors is AlphaVax, a Formerly VC-backed company based in Durham, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AlphaVax Formerly VC-backed Durham, NC
Aqualung Therapeutics Venture Capital-Backed Tucson, AZ
Enterprise Therapeutics Venture Capital-Backed Brighton, United Kingdom
The Zambon Group Private Debt Financed Bresso, Italy
Pacira BioSciences Formerly VC-backed Tampa, FL
You’re viewing 5 of 12 competitors. Get the full list »

Presidio Pharmaceuticals Patents

Presidio Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014055069-A1 Solid forms comprising an inhibitor of hcv ns5a, compositions thereof, and uses therewith Inactive 02-Oct-2012
WO-2013163466-A1 Inhibitors of hepatitis c virus Inactive 25-Apr-2012
AU-2013221613-A1 Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith Inactive 13-Feb-2012
CA-2864342-A1 Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith Inactive 13-Feb-2012
EP-2814322-A1 Solid forms comprising inhibitors of hcv ns5a, compositions thereof, and uses therewith Inactive 13-Feb-2012 C07D403/14
To view Presidio Pharmaceuticals’s complete patent history, request access »

Presidio Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Presidio Pharmaceuticals FAQs

  • When was Presidio Pharmaceuticals founded?

    Presidio Pharmaceuticals was founded in 2006.

  • Where is Presidio Pharmaceuticals headquartered?

    Presidio Pharmaceuticals is headquartered in San Francisco, CA.

  • What is the size of Presidio Pharmaceuticals?

    Presidio Pharmaceuticals has 12 total employees.

  • What industry is Presidio Pharmaceuticals in?

    Presidio Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Presidio Pharmaceuticals a private or public company?

    Presidio Pharmaceuticals is a Private company.

  • What is Presidio Pharmaceuticals’s current revenue?

    The current revenue for Presidio Pharmaceuticals is .

  • How much funding has Presidio Pharmaceuticals raised over time?

    Presidio Pharmaceuticals has raised $90.7M.

  • Who are Presidio Pharmaceuticals’s competitors?

    AlphaVax, Aqualung Therapeutics, Enterprise Therapeutics, The Zambon Group, and Pacira BioSciences are some of the 12 competitors of Presidio Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process